Activities of Gilles PARGNEAUX related to 2009/2103(INI)
Plenary speeches (1)
Commission communication on Action against Cancer: European Partnership (debate)
Shadow reports (1)
REPORT Report on the Commission communication on Action Against Cancer: European Partnership PDF (260 KB) DOC (165 KB)
Amendments (15)
Amendment 2 #
Motion for a resolution
Recital B
Recital B
B. whereas cancer was the second most common cause of death in 2006, accounting for two out of ten deaths in women and three out of ten deaths in men, equating to approximately 3.2 million EU citizens diagnosed with cancer each year; whereas the deaths are due for the most part to lung cancer, colorectal cancer, and breast cancer,
Amendment 12 #
Motion for a resolution
Recital H e (new)
Recital H e (new)
He. whereas, according to the World Health Organisation, at least 10% of annual cancer-related deaths are caused directly by exposure to carcinogens at the workplace; whereas such exposure could be averted if the carcinogens were replaced by less harmful substances,
Amendment 21 #
Motion for a resolution
Recital N a (new)
Recital N a (new)
Na. whereas crystalline silica is classed by the WHO as a Group 1 carcinogen and whereas 3.2 million workers in the EU are exposed to this substance for at least 75 % of their working time; whereas 2.7% of lung/bronchial cancer deaths have to be considered attributable to occupational exposure to crystalline silica,
Amendment 27 #
Motion for a resolution
Recital W a (new)
Recital W a (new)
Wa. whereas there are at present considerable qualitative differences within the EU as regards cancer screening, early detection, and follow-up; whereas the differences relate in particular to the application of procedures for the purposes of early detection, a method making for a cost measurable, cost-effective reduction in the impact of the disease,
Amendment 28 #
Motion for a resolution
Recital Z a (new)
Recital Z a (new)
Amendment 37 #
Motion for a resolution
Paragraph 3 a (new)
Paragraph 3 a (new)
3a. Calls on the Commission to specify the nature of, and the sources of funding for, the European Partnership for Action Against Cancer;
Amendment 49 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12a. Urges the Member States to establish a legal obligation to declare cancer cases, using standardised European terminology, the object being to provide means of evaluating prevention, screening, and treatment programmes, survival rates, and the comparability of data from one Member State to another and, on the basis of the findings, to produce information aimed at the general public;
Amendment 56 #
Motion for a resolution
Paragraph 16 a (new)
Paragraph 16 a (new)
16a. Notes that the Czech Government has not yet ratified the WHO Framework Convention on Tobacco Control, which entered into force in February 2005, and therefore urges it to do so;
Amendment 67 #
Motion for a resolution
Paragraph 18 a (new)
Paragraph 18 a (new)
18a. Calls on the Commission to encourage and support initiatives bringing together a wide range of stakeholders with the aim of preventing cancer by reducing occupational and environmental exposure to carcinogens and other cancer-producing substances and by promoting healthy lifestyles, not least by highlighting the main risk factors such as tobacco, alcohol, obesity, poor diet, lack of exercise, and exposure to the sun, placing the emphasis first and foremost on children and teenagers;
Amendment 69 #
Motion for a resolution
Paragraph 19 a (new)
Paragraph 19 a (new)
Amendment 70 #
Motion for a resolution
Paragraph 21 a (new)
Paragraph 21 a (new)
21a. Calls on the Commission, the Member States, and the European Chemicals Agency to implement Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals, enforce the applicable restrictions (REACH), and update the list of substances of very high concern, which covers carcinogens;
Amendment 71 #
Motion for a resolution
Paragraph 21 b (new)
Paragraph 21 b (new)
21b. Calls on the Commission, working within the Partnership, to encourage and support initiatives seeking to prevent imports of goods containing cancer- producing chemicals, and to take Europe- wide measures with a view to intensifying checks to detect such chemicals, pesticides included, as might be present in foodstuffs;
Amendment 73 #
Motion for a resolution
Paragraph 23 a (new)
Paragraph 23 a (new)
23a. Calls on the Commission and the Member States to ensure that EU-wide human bio-monitoring surveys receive the funding required to enable carcinogens and other cancer-producing substances to be monitored for the purpose of gauging policy effectiveness;
Amendment 74 #
Motion for a resolution
Paragraph 24 a (new)
Paragraph 24 a (new)
24a. Calls on the Commission to revise Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use (the Clinical Trials Directive) with a view to encouraging a greater cancer research effort, focusing in particular on screening, including early detection, without, however, disregarding the impact of the expenditure entailed on the non- commercial research sector, and to improve the information available to patients and the public at large about clinical trials in progress or which have been successfully completed;
Amendment 76 #
Motion for a resolution
Paragraph 26 a (new)
Paragraph 26 a (new)
26a. Calls on the Member States and the Commission to employ every means required to produce guidelines for a common definition of disability covering persons suffering from chronic diseases or from cancer and, in the meantime, ensure that those Member States which have not yet done so take the necessary steps without delay to include persons in the above categories in their national definitions of disability;